r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
<p>Abstract</p> <p>Background</p> <p>As EPO treatment of chronic anemia of advanced renal disease is now the standard of care we examined if such treatment may slow the progression of renal function decline.</p> <p>Methods</p> <p>Data of 18 pre-E...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2003-06-01
|
| Series: | BMC Nephrology |
| Online Access: | http://www.biomedcentral.com/1471-2369/4/3 |